<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03012633</url>
  </required_header>
  <id_info>
    <org_study_id>DC 2016/142</org_study_id>
    <nct_id>NCT03012633</nct_id>
  </id_info>
  <brief_title>Rapid Diagnostic of Hyperfibrinolysis in Liver Transplantation</brief_title>
  <acronym>FILYTHO</acronym>
  <official_title>Rapid Diagnostic of Hyperfibrinolysis in Liver Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      During liver transplantation (LT), hyperfibrinolysis is one of the most important&#xD;
      modification of haemostasis. It is associated with t-PA and protein C increased activity.&#xD;
      Hyperfibrinolysis is frequent, hardly predictable and associated with major bleeding. The&#xD;
      diagnostic of hyperfibrinolysis with standard laboratory tests (euglobulin lysis test, t-PA,&#xD;
      PAI-1 and D-dimers dosages) does not provide an answer in a delay compatible with the&#xD;
      clinical practice in the operating room.&#xD;
&#xD;
      The &quot;Lysis Timer&quot; is a device developed by Hyphen-Sysmex in collaboration with SD Innovation&#xD;
      and Charleroi University Hospital (Belgium). It allows the implementation of the &quot;Global&#xD;
      Fibrinolytic Capacity&quot;, or GFC test, in a complete system associating i) the reagents for in&#xD;
      vitro triggering of the clot and its lysis (contact system activators, t-PA, thrombin and&#xD;
      calcium), ii) the signal acquisition by the Lysis Timer (able to convert the analogic signal&#xD;
      of the absorbance modifications related to clot formation into a numeric signal) and iii) a&#xD;
      dedicated software treating the numeric signal to define clot lysis time.&#xD;
&#xD;
      The GFC test, using t-PA to shorten signal acquisition times, is particularly adapted to the&#xD;
      diagnosis of hyperfibrinolysis with PAI-1 collapse, of which LT is an example.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary aim of this prospective, monocentric, observational study is to evaluate the&#xD;
      Lysis Timer as a rapid diagnostic device for hyperfibrinolysis during liver transplantation.&#xD;
      Lysis times provided by this device will be compared to the euglobulin lysis times and to the&#xD;
      others parameters of fibrinolysis at the different stages of liver transplantation and more&#xD;
      specifically at the anhepatic stage and after graft revascularization.&#xD;
&#xD;
      The secondary aims are to compare the results of the Lysis Timer, the thromboelastogram, the&#xD;
      thrombin generation test and the standard laboratory tests in the context of&#xD;
      hyperfibrinolysis during liver transplantation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 9, 2017</start_date>
  <completion_date type="Actual">July 12, 2017</completion_date>
  <primary_completion_date type="Actual">June 14, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>clot lysis time</measure>
    <time_frame>during the liver transplantation surgery</time_frame>
    <description>clot lysis time obtained quickly with &quot;Lysis Timer &quot;is compared with standard laboratory tests to diagnose hyperfibrinolysis during liver transplantation surgery.</description>
  </primary_outcome>
  <enrollment type="Actual">30</enrollment>
  <condition>Liver Transplantation</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lysis timer</intervention_name>
    <description>Lysis Timer compared with standard laboratory test to diagnose hyperfibrinolysis during liver transplantation.</description>
    <other_name>Global Fibrinolytic Capacity</other_name>
    <other_name>GFC test</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        adult patients benefiting from liver transplantation&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adult patients benefiting from liver transplantation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age under eighteen&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandre OUATTARA, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>head of anesthesia department II</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>BORDEAUX UNIVERSITY HOSPITAL Haut Lévêque</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <study_first_submitted>January 5, 2017</study_first_submitted>
  <study_first_submitted_qc>January 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2017</study_first_posted>
  <last_update_submitted>December 13, 2017</last_update_submitted>
  <last_update_submitted_qc>December 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hyperfibrinolysis, Lysis Timer</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

